Tonix Pharmaceuticals Announces IND Clearance for TNX-601 ER as a Potential Treatment for Major Depressive Disorder - GlobeNewswire

Submitted by Anonymous (not verified) on Mon, 10/03/2022 - 11:00

Tonix Pharmaceuticals Announces IND Clearance for TNX-601 ER as a Potential Treatment for Major Depressive Disorder  GlobeNewswire